OPTIMUM trial demonstrates value of SKY92 in detecting high-risk myeloma and improving patient outcome
/PRNewswire/ -- SkylineDx, an innovative diagnostics company focused on research & development of molecular diagnostics for oncology and inflammatory diseases,...
Source: prnewswire.com